Satsuma Pharmaceuticals announces $US300m of funding for R&D in Australia

The pharmaceuticals giant Satsumas Australian subsidiary, has announced a $US100 million grant to research and develop new drugs for cancer, epilepsy and Alzheimer’s disease, with an aim to generate more than $US400 million by 2020.

The $US200 million grant will go towards creating new drugs with an effective cancer cure or a new class of drugs for seizure disorders.

The company said the funding would go towards “innovating new drugs in a wide range of indications”.

It will also help to support the development of new cancer drugs.

“Our research priorities for the next 12 months are focused on cancer and epilepsy as well as the potential for novel treatments for epilepsy, epilepsy disorders, Alzheimer’s, and other neurological disorders,” Satsume said in a statement.

“We have a great pipeline of promising candidates and we are now in the final stages of selection of promising drug candidates for the development and commercialisation of our therapies.”

The company’s chief executive, Tony Nunn, said the investment would support Satsuminas research into new treatments for cancer.

He said the company was “confident” the $US500 million funding would support the “development of new therapies in a range of conditions”.

“The funding will enable us to develop a portfolio of compounds that can help in the development, testing and commercialization of novel therapeutics for a range and/or class of cancers,” Mr Nunn said.

The Satsumenas announcement comes after a report in The New York Times last year said the Satsumi-owned company was facing competition from generic drugmakers.

“Australia is currently home to a substantial number of major pharmaceutical companies and research facilities,” the paper said.

“There are also significant domestic and international companies that are competing aggressively in this market.”

Satsums research into potential drugs for multiple diseases including Parkinson’s disease and Alzheimer`s disease.

“The next phase of development is to expand the clinical testing for all of the major diseases, particularly Parkinson’s and Alzheimer disease,” Sotsumas chief executive Tony Nott said in the statement.

The statement was released on Wednesday.

Sponsorship Levels and Benefits

카지노사이트 - NO.1 바카라 사이트 - [ 신규가입쿠폰 ] - 라이더카지노.우리카지노에서 안전 카지노사이트를 추천드립니다. 최고의 서비스와 함께 안전한 환경에서 게임을 즐기세요.메리트 카지노 더킹카지노 샌즈카지노 예스 카지노 코인카지노 퍼스트카지노 007카지노 파라오카지노등 온라인카지노의 부동의1위 우리계열카지노를 추천해드립니다.2021 베스트 바카라사이트 | 우리카지노계열 - 쿠쿠카지노.2021 년 국내 최고 온라인 카지노사이트.100% 검증된 카지노사이트들만 추천하여 드립니다.온라인카지노,메리트카지노(더킹카지노),파라오카지노,퍼스트카지노,코인카지노,바카라,포커,블랙잭,슬롯머신 등 설명서.【우리카지노】바카라사이트 100% 검증 카지노사이트 - 승리카지노.【우리카지노】카지노사이트 추천 순위 사이트만 야심차게 모아 놓았습니다. 2021년 가장 인기있는 카지노사이트, 바카라 사이트, 룰렛, 슬롯, 블랙잭 등을 세심하게 검토하여 100% 검증된 안전한 온라인 카지노 사이트를 추천 해드리고 있습니다.Best Online Casino » Play Online Blackjack, Free Slots, Roulette : Boe Casino.You can play the favorite 21 Casino,1xBet,7Bit Casino and Trada Casino for online casino game here, win real money! When you start playing with boecasino today, online casino games get trading and offers. Visit our website for more information and how to get different cash awards through our online casino platform.